前往化源商城

1246203-34-8

1246203-34-8结构式
1246203-34-8结构式

化源商城直购

英文名 4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline
英文别名 Benzenamine, 4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-
4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)aniline
4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl)-6-(4-morpholinyl)-1,3,5-triazin-2-yl)aniline
4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}aniline
密度 1.5±0.1 g/cm3
沸点 705.5±70.0 °C at 760 mmHg
分子式 C22H21F2N7O2
分子量 453.445
闪点 380.5±35.7 °C
精确质量 453.172485
PSA 104.21000
LogP 2.13
蒸汽压 0.0±2.2 mmHg at 25°C
折射率 1.700

~86%

1246203-34-8结构式

1246203-34-8

文献:PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; Location in patent: Page/Page column 46; 82-84 ; WO 2012/044641 A1

~%

1246203-34-8结构式

1246203-34-8

文献:PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; WO 2012/044641 A1
上游产品  2

下游产品  1